Intrathecal Injection of the Secretome from ALS Motor Neurons Regulated for miR-124 Expression Prevents Disease Outcomes in SOD1-G93A Mice
Open Access
- 29 August 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (9) , 2120
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with short life expectancy and no effective therapy. We previously identified upregulated miR-124 in NSC-34-motor neurons (MNs) expressing human SOD1-G93A (mSOD1) and established its implication in mSOD1 MN degeneration and glial cell activation. When anti-miR-124-treated mSOD1 MN (preconditioned) secretome was incubated in spinal cord organotypic cultures from symptomatic mSOD1 mice, the dysregulated homeostatic balance was circumvented. To decipher the therapeutic potential of such preconditioned secretome, we intrathecally injected it in mSOD1 mice at the early stage of the disease (12-week-old). Preconditioned secretome prevented motor impairment and was effective in counteracting muscle atrophy, glial reactivity/dysfunction, and the neurodegeneration of the symptomatic mSOD1 mice. Deficits in corticospinal function and gait abnormalities were precluded, and the loss of gastrocnemius muscle fiber area was avoided. At the molecular level, the preconditioned secretome enhanced NeuN mRNA/protein expression levels and the PSD-95/TREM2/IL-10/arginase 1/MBP/PLP genes, thus avoiding the neuronal/glial cell dysregulation that characterizes ALS mice. It also prevented upregulated GFAP/Cx43/S100B/vimentin and inflammatory-associated miRNAs, specifically miR-146a/miR-155/miR-21, which are displayed by symptomatic animals. Collectively, our study highlights the intrathecal administration of the secretome from anti-miR-124-treated mSOD1 MNs as a therapeutic strategy for halting/delaying disease progression in an ALS mouse model.Keywords
Funding Information
- Santa Casa da Misericórdia de Lisboa (ELA-2015-002, PTDC/MED-NEU/31395/2017, UIDB/UIDP/04138/2020, UID/DTP/04138/2019-2020, LISBOA-01-0145-FEDER-031395, HR21-00931, SFRH/BD/129586/2017, PPBI-POCI-01-0145-FEDER-022122)
- Fundação para a Ciência e a Tecnologia (FCT) (ELA-2015-002, PTDC/MED-NEU/31395/2017, UIDB/UIDP/04138/2020, UID/DTP/04138/2019-2020, LISBOA-01-0145-FEDER-031395, HR21-00931, SFRH/BD/129586/2017, PPBI-POCI-01-0145-FEDER-022122)
- Programa Operacional Regional de Lisboa (ELA-2015-002, PTDC/MED-NEU/31395/2017, UIDB/UIDP/04138/2020, UID/DTP/04138/2019-2020, LISBOA-01-0145-FEDER-031395, HR21-00931, SFRH/BD/129586/2017, PPBI-POCI-01-0145-FEDER-022122)
- La Caixa Foundation (ELA-2015-002, PTDC/MED-NEU/31395/2017, UIDB/UIDP/04138/2020, UID/DTP/04138/2019-2020, LISBOA-01-0145-FEDER-031395, HR21-00931, SFRH/BD/129586/2017, PPBI-POCI-01-0145-FEDER-022122)
- individual fellowship from FCT (ELA-2015-002, PTDC/MED-NEU/31395/2017, UIDB/UIDP/04138/2020, UID/DTP/04138/2019-2020, LISBOA-01-0145-FEDER-031395, HR21-00931, SFRH/BD/129586/2017, PPBI-POCI-01-0145-FEDER-022122)
- ICVS Scientific Microscopy Platform (ELA-2015-002, PTDC/MED-NEU/31395/2017, UIDB/UIDP/04138/2020, UID/DTP/04138/2019-2020, LISBOA-01-0145-FEDER-031395, HR21-00931, SFRH/BD/129586/2017, PPBI-POCI-01-0145-FEDER-022122)
This publication has 110 references indexed in Scilit:
- Assessment of Sensorimotor Function in Mouse Models of Parkinson's DiseaseJournal of Visualized Experiments, 2013
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosisNature Neuroscience, 2013
- Efficient recovery of proteins from multiple source samples after trizol® or trizol®LS RNA extraction and long-term storageBMC Genomics, 2013
- Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR‐124 and reduced AMPA receptorsAnnals of Neurology, 2013
- Optimised and Rapid Pre-clinical Screening in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)PLOS ONE, 2011
- Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcomeBrain Research, 2011
- Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic miceHuman Molecular Genetics, 2010
- MFG-E8 Regulates Microglial Phagocytosis of Apoptotic NeuronsJournal of Neuroimmune Pharmacology, 2008
- Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosisThe Journal of Physiology, 2008
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993